This study compares placebo with Aricept to see if cognitive function improves over 12 weeks. The purpose of this study is to look at a new method for blocking the VLA-4 adhesion molecule that allows white blood cells to stick to blood vessels in the brain. This study requires a monthly infusion of a monoclonal antibody for six months, with follow-up for an additional six months. Participants will receive monthly MRI exams. No further information is available on these possible upcoming studies, as they are in the early planning stages.
Enrollment is closed.
Participants will receive monthly MRI exams. Oral Copaxone Study ongoing. Enrollment is closed. This study evaluates the efficacy of oral Copaxone in reducing relapse rates and new MRI lesions. Enrollment is closed.